Semler Scientific (SMLR) Revenue & Revenue Breakdown
Semler Scientific Revenue Highlights
Latest Revenue (Y)
$68.18M
Latest Revenue (Q)
$13.51M
Semler Scientific Revenue by Period
Semler Scientific Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $68.18M | 20.28% |
| 2022-12-31 | $56.69M | 6.90% |
| 2021-12-31 | $53.03M | 37.36% |
| 2020-12-31 | $38.60M | 17.81% |
| 2019-12-31 | $32.77M | 52.47% |
| 2018-12-31 | $21.49M | 72.59% |
| 2017-12-31 | $12.45M | 67.50% |
| 2016-12-31 | $7.43M | 6.18% |
| 2015-12-31 | $7.00M | 92.60% |
| 2014-12-31 | $3.63M | 59.85% |
| 2013-12-31 | $2.27M | 89.66% |
| 2012-12-31 | $1.20M | 279.43% |
| 2011-12-31 | $316.00K | - |
Semler Scientific generated $68.18M in revenue during NA 2023, up 20.28% compared to the previous quarter, and up 317.27% compared to the same period a year ago.
Semler Scientific Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $13.51M | -6.59% |
| 2024-06-30 | $14.46M | -9.04% |
| 2024-03-31 | $15.90M | 5.63% |
| 2023-12-31 | $15.06M | -7.72% |
| 2023-09-30 | $16.32M | -12.30% |
| 2023-06-30 | $18.61M | 2.19% |
| 2023-03-31 | $18.21M | 31.98% |
| 2022-12-31 | $13.79M | -1.80% |
| 2022-09-30 | $14.05M | -5.27% |
| 2022-06-30 | $14.83M | 5.79% |
| 2022-03-31 | $14.02M | 21.43% |
| 2021-12-31 | $11.54M | -17.50% |
| 2021-09-30 | $13.99M | -2.24% |
| 2021-06-30 | $14.31M | 8.56% |
| 2021-03-31 | $13.18M | 9.19% |
| 2020-12-31 | $12.07M | 12.55% |
| 2020-09-30 | $10.73M | 68.32% |
| 2020-06-30 | $6.37M | -32.42% |
| 2020-03-31 | $9.43M | 3.05% |
| 2019-12-31 | $9.15M | 2.80% |
| 2019-09-30 | $8.90M | 11.93% |
| 2019-06-30 | $7.95M | 17.63% |
| 2019-03-31 | $6.76M | 13.36% |
| 2018-12-31 | $5.96M | 6.90% |
| 2018-09-30 | $5.58M | 1.73% |
| 2018-06-30 | $5.48M | 22.88% |
| 2018-03-31 | $4.46M | 5.93% |
| 2017-12-31 | $4.21M | 16.80% |
| 2017-09-30 | $3.61M | 39.91% |
| 2017-06-30 | $2.58M | 25.45% |
| 2017-03-31 | $2.06M | -11.27% |
| 2016-12-31 | $2.32M | 16.85% |
| 2016-09-30 | $1.98M | 21.15% |
| 2016-06-30 | $1.64M | 8.99% |
| 2016-03-31 | $1.50M | -48.84% |
| 2015-12-31 | $2.93M | 87.84% |
| 2015-09-30 | $1.56M | 19.88% |
| 2015-06-30 | $1.30M | 8.40% |
| 2015-03-31 | $1.20M | 13.93% |
| 2014-12-31 | $1.05M | 17.61% |
| 2014-09-30 | $897.00K | 6.03% |
| 2014-06-30 | $846.00K | 1.08% |
| 2014-03-31 | $837.00K | 7.17% |
| 2013-12-31 | $781.00K | 32.60% |
| 2013-09-30 | $589.00K | 24.00% |
| 2013-06-30 | $475.00K | 10.72% |
| 2013-03-31 | $429.00K | 0.47% |
| 2012-12-31 | $427.00K | 37.74% |
| 2012-09-30 | $310.00K | - |
Semler Scientific generated $13.51M in revenue during Q3 2024, up -6.59% compared to the previous quarter, and up 72.63% compared to the same period a year ago.
Semler Scientific Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LIVN | LivaNova | $1.15B | $318.11M |
| AORT | Artivion | $354.00M | $95.78M |
| INGN | Inogen | $315.66M | $88.83M |
| TMDX | TransMedics Group | $241.62M | $-12.24M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| LUNG | Pulmonx | $68.67M | $20.39M |
| SMLR | Semler Scientific | $68.18M | $13.51M |
| NPCE | NeuroPace | $65.42M | $21.06M |
| TELA | TELA Bio | $58.45M | $18.96M |
| APYX | Apyx Medical | $52.35M | $16.02M |
| CVRX | CVRx | $39.30M | $13.37M |
| OSA | ProSomnus | $27.65M | $7.46M |
| DCTH | Delcath Systems | $2.06M | $9.56M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |